Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Cigna Corporation
  6. Summary
    CI   US1255231003

CIGNA CORPORATION

(CI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
239.59(c) 239.08(c) 236.99(c) 236.69(c) 231.97(c) Last
1 471 539 2 252 091 2 040 758 2 592 103 4 230 016 Volume
-0.93% -0.21% -0.87% -0.13% -1.99% Change
More quotes
Financials (USD)
Sales 2021 167 B - -
Net income 2021 5 441 M - -
Net Debt 2021 24 716 M - -
P/E ratio 2021 14,6x
Yield 2021 2,16%
Sales 2022 176 B - -
Net income 2022 6 252 M - -
Net Debt 2022 21 636 M - -
P/E ratio 2022 12,3x
Yield 2022 2,26%
Capitalization 79 599 M 79 599 M -
EV / Sales 2021 0,63x
EV / Sales 2022 0,57x
Nbr of Employees 72 963
Free-Float 86,0%
More Financials
Company
Cigna Corporation is a health services company that offers medical, dental insurance and related products and services. The Company's segments are Evernorth, U.S. Medical and International Markets. The Company's Evernorth segment is engaged in offering coordinated and point solution health services, including Pharmacy Solutions, Benefits Management Solutions, Care Solutions, Evernorth Intelligence Solutions, and... 
Read more
Sector
Managed Healthcare
Calendar
06/19 | 11:20amPresentation
More about the company
Ratings of Cigna Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about CIGNA CORPORATION
06/16CIGNA  : Survey Confirms Mental Health Services and Support Critical to Global P..
AQ
06/16EISAI  : First patient receives controversial Biogen Alzheimer's drug
RE
06/07First New Alzheimer's Drug in Nearly Two Decades Is Approved by FDA -- 5th Up..
DJ
06/07BIOGEN  : What does FDA approval of Biogen's Alzheimer's drug mean for patients?
RE
06/07First New Alzheimer's Drug in Nearly Two Decades Is Approved by FDA -- 4th Up..
DJ
06/07First New Alzheimer's Drug in Nearly Two Decades Is Approved by FDA -- 3rd Up..
DJ
06/07First New Alzheimer's Drug in Nearly Two Decades Is Approved by FDA -- 2nd Up..
DJ
06/07First New Alzheimer's Drug in Nearly Two Decades Is Approved by FDA -- Update
DJ
06/07First Alzheimer's Drug to Slow Disease Is Approved by FDA
DJ
06/07CIGNA CORPORATION : Ex-dividend day for
FA
06/03CIGNA  : Morgan Stanley Adjusts Price Target on Cigna to $321 From $254, Maintai..
MT
05/28CIGNA  : Reaffirms Full-Year 2021 Revenue, Earnings
MT
05/28CIGNA  : Regulation FD Disclosure (Form 8-K)
PU
05/28CIGNA CORP  : Regulation FD Disclosure (form 8-K)
AQ
05/20CIGNA  : Administered by Oscar Expands Affordable, Innovative Health Plans for S..
BU
More news
News in other languages on CIGNA CORPORATION
05/07EN DIRECT DES MARCHES  : Crédit Agricole, Klépierre, Casino, Rubis, Adidas, BMW,..
2020EN DIRECT DES MARCHES  : ArcelorMittal, Société Générale, Veolia, CGG, Lufthansa..
2020Haut les masques !
2020EN DIRECT DES MARCHES : Suez, Lagardère, Sanofi, Ubisoft, Apple, AstraZeneca,..
2020CIGNA CORPORATION  : Paradoxalement, une baisse des coûts médicaux
More news
Analyst Recommendations on CIGNA CORPORATION
More recommendations
Analysis
Amazon launches online pharmacy in new contest with drug retail
Chart CIGNA CORPORATION
Duration : Period :
Cigna Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 294,43 $
Last Close Price 231,97 $
Spread / Highest target 38,4%
Spread / Average Target 26,9%
Spread / Lowest Target -0,85%
EPS Revisions
Managers and Directors
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Brian C. Evanko Chief Financial Officer & Executive Vice President
Isaiah Harris Independent Chairman
Steven B. Miller Chief Clinical Officer & Executive Vice President
Noelle K. Eder Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION11.43%79 599
UNITEDHEALTH GROUP11.03%367 449
ANTHEM, INC.14.99%90 398
HUMANA INC.3.22%54 638
CENTENE CORPORATION19.42%41 776
MOLINA HEALTHCARE, INC.12.63%13 989